翻译成英文以2年复发转移率为主要指标探索呋喹替尼作为晚期CRC获得NED完成辅助化疗后维持治疗的临床有效性和安全性
Explore the clinical effectiveness and safety of fruquintinib as maintenance therapy in advanced CRC patients achieving NED after completing adjuvant chemotherapy, with a focus on the 2-year recurrence and metastasis rate as the primary outcome measure.
原文地址: https://www.cveoy.top/t/topic/hHTJ 著作权归作者所有。请勿转载和采集!